Skip to main content Accessibility help
  • Print publication year: 2005
  • Online publication date: September 2009

7 - Acute metabolic illness in the newborn


There are few situations in clinical medicine as acutely stressful as the precipitate deterioration of a previously healthy newborn infant, coupled with the recognition that, irrespective of the cause, delay in the initiation of appropriate management often leads to death or irreparable brain damage. Severe illness in the newborn, regardless of the underlying cause, tends to manifest itself in a rather stereotypic way with relatively nonspecific findings, such as poor feeding, drowsiness, lethargy, hypotonia, and failure to thrive. Because inherited metabolic diseases are individually rare, clinicians have a tendency to pursue the possibility only after other more common conditions, such as sepsis, have been excluded. Further delay often occurs because the type of investigation required to make the diagnosis of inherited metabolic disease includes unfamiliar tests, which the clinician may feel uncomfortable interpreting owing to a general lack of confidence regarding metabolic problems.

The need for dispatch requires that inborn errors of metabolism be considered along with and at the same time as common acquired conditions, such as sepsis, hypoxic-ischemic encephalopathy, intraventricular hemorrhage, intoxications, congenital viral infections, and certain types of congenital heart disease. Appropriate laboratory investigation, including some simple bedside tests, such as urine tests for reducing substances and ketones, should be initiated without delay, even done at the bedside if possible. Despite the apparent non-specificity of presenting symptoms in neonates, there are some features that increase the likelihood of an inborn error of metabolism.

Related content

Powered by UNSILO
Burton, B. K. (1998). Inborn errors of metabolism in infancy: a guide to diagnosis. Pediatrics, 102, E69.
Cornblath, M. & Ichord, R. (2000). Hypoglycemia in the neonate. Seminars in Perinatology, 24, 136–49.
Ellaway, C. J., Wilcken, B. & Christodoulou, J. (2002). Clinical approach to inborn errors of metabolism presenting in the newborn period. Journal of Paediatrics and Child Health, 38, 511–517.
Leonard, J. V. & Morris, A. A. (2000). Inborn errors of metabolism around the time of birth. Lancet, 356, 583–7.
Ogier de Baulny, H. (2002). Management and emergency treatments of neonates with a suspicion of inborn errors of metabolism. Seminars in Neonatology, 7, 17–26.
Rinaldo, P., Yoon, H.-R., Yu, C., Raymond, K., Tiozzo, C. & Giordano, G. (1999). Sudden and unexpected neonatal death: a protocol for the postmortem diagnosis of fatty acid oxidation disorders. Seminars in Perinatology, 23, 204–10.
Saudubray, J. M., Nassogne, M. C., Lonlay, P. & Touati, G. (2002). Clinical approach to inherited metabolic disorders in neonates: an overview. Seminars in Neonatology, 7, 3–15.
Stone, D. L. & Sidransky, E. (1999). Hydrops fetalis: lysosomal storage disorders in extremis. Advances in Pediatrics, 46, 409–40.
Sue, C. M., Hirano, M., DiMauro, S. & Vivo, D. C. (1999). Neonatal presentations of mitochondrial metabolic disorders. Seminars in Perinatology, 23, 113–24.
Tein, I. (1999). Neonatal metabolic myopathies. Seminars in Perinatology, 23, 125–51.